Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.
Pezzolo A, Sementa AR, Lerone M, Morini M, Ognibene M, Defferrari R, Mazzocco K, Conte M, Gigliotti AR, Garaventa A, Pistoia V, Varesio L. Pezzolo A, et al. Among authors: morini m. Cancer Biol Ther. 2017 May 4;18(5):285-289. doi: 10.1080/15384047.2017.1312231. Epub 2017 Apr 12. Cancer Biol Ther. 2017. PMID: 28402723 Free PMC article.
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study.
Morini M, Cangelosi D, Segalerba D, Marimpietri D, Raggi F, Castellano A, Fruci D, de Mora JF, Cañete A, Yáñez Y, Viprey V, Corrias MV, Carlini B, Pezzolo A, Schleiermacher G, Mazzocco K, Ladenstein R, Sementa AR, Conte M, Garaventa A, Burchill S, Luksch R, Bosco MC, Eva A, Varesio L. Morini M, et al. Cancers (Basel). 2019 Sep 30;11(10):1476. doi: 10.3390/cancers11101476. Cancers (Basel). 2019. PMID: 31575060 Free PMC article.
Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.
Amoroso L, Ognibene M, Morini M, Conte M, Di Cataldo A, Tondo A, D'Angelo P, Castellano A, Garaventa A, Lasorsa VA, Podestà M, Capasso M, Pezzolo A. Amoroso L, et al. Among authors: morini m. Genes Chromosomes Cancer. 2020 May;59(5):277-285. doi: 10.1002/gcc.22827. Epub 2019 Dec 3. Genes Chromosomes Cancer. 2020. PMID: 31756773
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
Dondero A, Morini M, Cangelosi D, Mazzocco K, Serra M, Spaggiari GM, Rotta G, Tondo A, Locatelli F, Castellano A, Scuderi F, Sementa AR, Eva A, Conte M, Garaventa A, Bottino C, Castriconi R. Dondero A, et al. Among authors: morini m. J Immunother Cancer. 2021 Apr;9(4):e002293. doi: 10.1136/jitc-2020-002293. J Immunother Cancer. 2021. PMID: 33795387 Free PMC article.
FGFR1 is a potential therapeutic target in neuroblastoma.
Cimmino F, Montella A, Tirelli M, Avitabile M, Lasorsa VA, Visconte F, Cantalupo S, Maiorino T, De Angelis B, Morini M, Castellano A, Locatelli F, Capasso M, Iolascon A. Cimmino F, et al. Among authors: morini m. Cancer Cell Int. 2022 Apr 29;22(1):174. doi: 10.1186/s12935-022-02587-x. Cancer Cell Int. 2022. PMID: 35488346 Free PMC article.
291 results